Business News

Symbiotec Pharmalab IPO opens today: GMP signals 41% upside — Should you subscribe?

FinSiddhi

Symbiotec Pharmalab’s Rs 1,757 crore IPO opens August 24, with a Rs 938–988 price band and 41% grey-market premium. The issue combines fresh shares and an OFS, while proceeds will partly repay debt. Its specialised API manufacturing, regulatory approvals and biotechnology capabilities offer investors exposure to India’s pharmaceutical manufacturing growth.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

A town in the Netherlands will not let you live there unless you grow food on at least half of your land

Oosterwold, a Dutch town, mandates residents cultivate food on their properties. This unique urban experiment balances nature and living with low density. Residents manage their plots, growing produce for personal use and local businesses. A food hub offers resources to assist residents with agricultural practices. This initiative aims to enhance sustainability and the area’s agricultural…

‘Could result in injury or death’: Thanedar urges halting ICE’s electric shock glove plan

Indian-American Congressman Shri Thanedar and colleagues oppose ICE’s electric shock glove plan. They warn of potential misuse and severe injury or death from these devices. Lawmakers cite ICE’s past record and insufficient training for officers. The proposed procurement involves millions of dollars for thousands of gloves. They implore the Homeland Security Secretary to immediately stop…